Immune checkpoint inhibitorsmelanomanon-small cell lungStomach cancerLancet OncolImmune Checkpoint InhibitorsWorld Bankkidneykidney cancer
…Background Immune checkpoint inhibitors (ICIs) have redefined treatment for high-burden cancers such as…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 3,001–3,060 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
basal-bolus insulin therapy1behavioural and addiction-related treatments1behavioural measures1best supportive care1better treatment1bicarbonate therapy1bifurcated prosthetic vascular graft1bilateral ONBs1bilateral TAP block1bilateral adrenalectomy1bilateral cataract surgery1bilateral double-J stenting1bilateral oophorectomy1bilateral pelvic lymphadenectomy1bilateral salpingo-oopherectomy1bilateral stenting1bilateral total hip replacement1bilateral total knee replacement1bile acid sequestrants1biliary brushings1biliary drainage1bilirubin-based screening1biologic agents1biologic treatments1biological treatment1biologics therapies1bioprosthetic aortic valve replacement1bismuth quadruple therapy1bismuth-containing quadruple therapy1bispecific T-cell engager therapy1bispecific antibodies1bisphosphonates1biventricular resynchronisation therapy1bland dressings1blood glucose control1blood pressure lowering1blood pressure optimisation1bone marrow transplantation1botulinum injections1bowel management1braided stent1brain–gut behaviour therapy1breast cancer treatment1breathing control training1breathing pattern retraining1bronchiectasis therapies1bronchodilation1bronchodilator regime1bronchodilator response1burr hole evacuation surgery1bypass1bypass surgery1c-DMARDs1c-MITS1cCBT1cadaveric injections1calcitonin gene-related peptide-targeted migraine treatments1cancer care1cancer drugs1cancer immunotherapy treatment1
Articles mentioning treatments
7,227 articles · page 489 of 603Neoadjuvant strategiesnivolumabcabozantinibimCORE Grant 142583Hepatocellular carcinoma (HCC)Johns HopkinsEthicsNCT03299946
…mary liver cancers and is frequently unresectable at diagnosis. Neoadjuvant strategies aimed at downsizing tumors may enable curative resection in the…
Adoptive cell therapiesmelanomacyclophosphamideneuroblastomaNBcolorectalC57BL/6 mice
…Background Adoptive cell therapies, including T and natural killer T (NKT) cells expressing GD2-sp…
anti-PD-1 therapyNSCLCnon-small cell lung cancerCheckpoint inhibitors
…models in mice to identify targets which restore sensitivity to anti-PD-1 therapy.Results Knockout of MGAT1, an enzyme critical for maturation of…
ICBrenal clear cell carcinomaCCL20renal cell carcinomaccRCCNature Biotechnologyadvanced clear cell renal cell carcinomaOncology Research Exchange Network
… first to propose 14q- coupled with FTL3 can positively predict ICB response in ccRCC.References Matthew Kyle L, Jason Z, Rajan G, …
76.0%
immune checkpoint blockadeIFN-β
…y may potentiate durable anti-tumor immunity when combined with immune checkpoint blockade. Utilizing high throughput CRISPR-Cas9 screening assays, our gr…
tumor treatmentTarlatamabTalquetamabDLL3 TCE
…gen (TAA) on cancer cells, have demonstrated great potential in tumor treatment. Due to the complex mechanism of TCE molecules, advanced models…
immunotherapyprostate cancercolorectal cancerlung cancerbreast cancerlymphomamelanomaHiPlex Pro
…mor-immune interface and identify functional states relevant to immunotherapy and disease progression.References Ferri-Borgogno S, et al. Mol…
HER2-targeting ADCsbreast cancerstrastuzumab emtansinenon-small cell lung cancersChampions OncologystaurosporineHER2-driven cancers
…SO) to establish Z′-factor metrics. Organoids were treated with HER2-targeting ADCs (e.g., trastuzumab emtansine), payload-only controls, and isoty…
immunotherapiesuterine Leiomyosarcoma
…are ideal targets for effective anti-tumor immune responses and immunotherapies; however, for their clinical application, more accurate and eff…
immunotherapyLung cancerNSCLC
…s of the tumor microenvironment (TME) predictive of response to immunotherapy. Using a combination of protein- and RNA-based -omic technologi…
immunotherapyUniversity of PittsburghNSCLCsolid tumors
…that could be used to modulate TLS in solid tumors for improved immunotherapy response.Ethics Approval This study was approved by the Univers…